Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
29 May 2014 04:52 PM
RNS
Notice of posting of prospectus
29 May 2014 07:00 AM
RNS
Fundraising and Open Offer
22 May 2014 09:22 AM
RNS
Director Declaration
13 May 2014 07:00 AM
RNS
Interim Management Statement
02 May 2014 04:57 PM
RNS
2013 ANNUAL REPORT AND ACCOUNTS & AGM NOTIFICATION
30 Apr 2014 07:00 AM
RNS
?2.2 Million Grant Received from TSB
29 Apr 2014 07:00 AM
RNS
Oxford BioMedica provides update on RetinoStat?
10 Apr 2014 07:00 AM
RNS
Final Results
07 Apr 2014 07:00 AM
RNS
OXB completes patient recruitment into RetinoStat
03 Apr 2014 07:00 AM
RNS
Notice of Results
21 Mar 2014 07:00 AM
RNS
OXB Present at Regen Med Investor Day
17 Feb 2014 07:00 AM
RNS
Oxford BioMedica and Sanofi Amend Terms for Ocular
17 Jan 2014 04:40 PM
RNS
Second Price Monitoring Extn
17 Jan 2014 04:35 PM
RNS
Price Monitoring Extension
10 Jan 2014 07:00 AM
RNS
Publication of ProSavin Phase I/II Study
09 Jan 2014 12:19 PM
RNS
Oxford BioMedica to Present at Biotech Showcase
06 Jan 2014 10:28 AM
RNS
Oxford Biomedica PLC - General Meeting
18 Dec 2013 07:00 AM
RNS
OXB option agreement with GSK
11 Dec 2013 07:00 AM
RNS
CIRCULAR & GENERAL MEETING NOTIFICATION
22 Nov 2013 12:38 PM
RNS
Director/PDMR Shareholding
19 Nov 2013 07:00 AM
RNS
?5 million Loan Facility from Lead Shareholder
19 Nov 2013 07:00 AM
RNS
Interim Management Statement
17 Oct 2013 07:00 AM
RNS
Agreement to Resume Clinical Trials
19 Sep 2013 07:00 AM
RNS
Director/PDMR Shareholding
17 Sep 2013 01:06 PM
RNS
Block Listing Return
12 Sep 2013 11:18 AM
RNS
Oxford BioMedica plc Director's Share Purchase
11 Sep 2013 01:01 PM
RNS
Oxford BioMedica Wins Significant Funding
06 Sep 2013 04:40 PM
RNS
Second Price Monitoring Extn
06 Sep 2013 04:35 PM
RNS
Price Monitoring Extension
29 Aug 2013 04:08 PM
RNS
TR1 Form
29 Aug 2013 07:00 AM
RNS
Interim Results 2013
28 Aug 2013 07:00 AM
RNS
US$1 million Milestone Payment from Pfizer
14 Aug 2013 01:00 PM
RNS
Announced as Funding Competition Winner
29 Jul 2013 07:00 AM
RNS
Publication of TroVax Phase II Analyses
23 Jul 2013 07:00 AM
RNS
Notice of Interim Results
16 Jul 2013 11:20 AM
RNS
Director/PDMR Shareholding
01 Jul 2013 07:00 AM
RNS
Update on Glaucoma-GT
28 Jun 2013 07:00 AM
RNS
Total Voting Rights
20 Jun 2013 11:15 AM
RNS
Director/PDMR Shareholding
19 Jun 2013 11:00 AM
RNS
TR-1: Notification of Major Interest in Shares
12 Jun 2013 07:00 AM
RNS
Directors' Interests in Share Options
10 Jun 2013 12:59 PM
RNS
Director/PDMR Shareholding
10 Jun 2013 12:59 PM
RNS
TR-1: Notification of Major Interest in Shares
10 Jun 2013 07:00 AM
RNS
Director's Share Purchase
06 Jun 2013 11:45 AM
RNS
Result of AGM
06 Jun 2013 07:00 AM
RNS
Change of Adviser and Broker
06 Jun 2013 07:00 AM
RNS
Management and Board change
05 Jun 2013 10:43 AM
RNS
TR-1: Notification of Major Interest in Shares
03 Jun 2013 07:00 AM
RNS
Clinical Trial Update
24 May 2013 10:00 AM
RNS
BLOCK LISTING RETURN

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings